|
Test Catalog
|
|
EGR2 DNA Sequencing Test |
#248 |
|
| Type of Disorder: |
Peripheral Neuropathy |
|
| Typical Presentation: |
CMT with a family history of EGR2 mutations identified in a proband |
|
| Disease(s) tested for: |
Congenital hypomyelination neuropathy, Dejerine-Sottas syndrome, CMT1D, CMT4E, Charcot-Marie-Tooth Disease, Type 1C (CMT1C) |
|
| Test Details |
|
| Test Code: |
248 |
|
| Profiles that contain this test: |
Complete CMT Evaluation, Complete Dejerine-Sottas Neuropathy Evaluation, Congenital Hypomyelination Evaluation, Dominant CMT Evaluation, Partial CMT Evaluation - Demyelinating Only, Partial CMT Evaluation - Recessive Only
|
|
| Informed Consent Required: |
Yes |
|
| Medicare ABN Required: |
No |
|
| Special Notes: |
Unless a family member has been confirmed by prior testing, it is recommended that this test be done as part of the Complete CMT Evaluation, #390. |
|
| Technical Information |
|
| Utility: |
Detects sequence variations in the EGR2 gene |
|
| Methodology: |
Polymerase Chain Reaction (PCR) and DNA sequencing |
|
| Reference Value: |
No sequence variation detected |
|
| CPT Code(s): |
83891(1), 83898(5), 83904(5), 83909(1), 83912(1) |
|
| Patents: |
N/A |
|
| Shipping Considerations |
|
| Preferred Specimen Requirements |
| Type: |
Whole blood |
| Minimum Volume: |
10ml |
| Collection Tube: |
Lavender (EDTA) |
|
| Alternate
Specimen Requirements |
| Type: |
Whole blood |
| Minimum Volume: |
10ml |
| Collection Tube: |
lavender top (EDTA) |
|
| Storage Conditions: |
Room temperature, avoid freezing |
|
| Shipping Conditions: |
Overnight, room temperature |
|
| Test Turnaround: |
14-21 days |
|
|
[back to top]
|
